R. Blamey

R W Blamey, R. Blamey, S K Al-Ghazal, 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Subcutaneous mastectomy with implant reconstruction: cosmetic outcome and patient satisfaction.

R. Blamey, S. Al-Ghazal, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer.

R. Blamey, S. Al-Ghazal, L. Fallowfield, 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Terry L. Smith, R. Collins, L. Holmberg, 1998, Lancet.

LH-RH Agonists for the Treatment of Breast Cancer

R. Blamey, 2009 .

Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer.

J. Cuzick, W. Sauerbrei, R. Blamey, 2003, European journal of cancer.

Management of physiological gynaecomastia with tamoxifen.

R. Blamey, R. Rampaul, H. N. Khan, 2004, Breast.

Selective use of post-mastectomy flap irradiation in high-risk breast cancer patients.

R. Blamey, S. Pinder, R. Macmillan, 2005, Breast.

Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens.

I. Ellis, R. Mansel, R. Blamey, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Should women be advised to take prophylactic endocrine treatment outside of a clinical trial setting?

R. Blamey, H. Gogas, C. Markopoulos, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Carcinoembryonic antigen (CEA): its role as a tumour marker in breast cancer.

R. Blamey, R. Nicholson, P. Doyle, 1981, Clinics in oncology.

MAMMOGRAPHY IN SYMPTOMATIC BREAST DISEASE

R. Blamey, A. Manhire, A. Locker, 1989, The Lancet.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Prognostic significance of serum c-erbB-2 protein in breast cancer patients

I. Ellis, R. Blamey, S. Pinder, 2005, Breast Cancer Research and Treatment.

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.

A. Howell, R. Blamey, J. Robertson, 1996, British Journal of Cancer.

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

W. Sauerbrei, R. Blamey, M. Schumacher, 2003, Osteoporosis International.

cancer ABC of breast diseases : Screening for breast

R. Blamey, J. Patnick, 2000 .

re: Family history screening and breast cancer

A. Howell, R. Blamey, J. Kollias, 1997 .

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.

I. Ellis, R. Blamey, C. Elston, 1988, BMJ.

Chemotherapy‐induced differential changes in lymphocyte subsets and natural‐killer‐cell function in patients with advanced breast cancer

R. Blamey, H. Sewell, S. Chan, 1993, International Journal of Cancer.

Update of the BASO II trial of primary treatment of tumours of excellent prognosis

R. Blamey, M. Mitchell, D. Morgan, 2004 .

Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation

R. Blamey, S. J. Smith, M. Bishop, 1994, The British journal of surgery.

Characteristics of cadaveric renal allograft recipients developing chronic rejection.

R. Blamey, P. Rowe, R. Burden, 1990, Annals of the Royal College of Surgeons of England.

The 1989 Walter Hubert lecture. Does biological understanding influence surgical practice?

R. Blamey, 1989, British Journal of Cancer.

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.

R W Blamey, I. Ellis, R. Blamey, 2006, European journal of cancer.

QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPY

R. Blamey, K. Griffiths, C. Elston, 1981, The Lancet.

PP-3-20 local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (dcis) of the breast

I. Ellis, R. Blamey, S. Pinder, 1996 .

Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.

M. Williams, R. Blamey, K. Griffiths, 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Calcium excretion (CaE) in metastatic breast cancer

R. Blamey, C. Elston, F. Campbell, 1983, The British journal of surgery.

Advances in the management of metastatic bone disease

R. Blamey, R. Rubens, P. Conte, 1994 .

The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma.

R. Blamey, K. Griffiths, C. Elston, 1980, European journal of cancer.

Prognostic value of immunocytochemistry of the primary tumour in patients with metastatic breast cancer

I. Ellis, R. Blamey, C. Elston, 1995 .

Bone scanning: Its lack of value in the follow‐up of patients with breast cancer

R. Blamey, P. Doyle, A. Morris, 1979, The British journal of surgery.

Estrogen receptors and breast cancer.

R. Blamey, K. Griffiths, R. Nicholson, 1981, Environmental health perspectives.

Carcinoma of the breast imaged by nuclear magnetic resonance (NMR).

R. Ordidge, P. Mansfield, R. Blamey, 1979, The British journal of radiology.

O-59 Identification of sub-classes of breast cancer through consensus derived from automated clustering methods

Paulo J. G. Lisboa, Jonathan M. Garibaldi, Elia Biganzoli, 2007 .

The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss.

R. Blamey, P. Rowe, R. Burden, 1989, Annals of the Royal College of Surgeons of England.

An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.

M. Williams, R. Blamey, K. Griffiths, 1990, British Journal of Cancer.

The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.

M. Williams, R. Blamey, K. Griffiths, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast.

R. W. Baldwin, M. Williams, R. Blamey, 1984, Clinical oncology.

Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.

M. Williams, R. Blamey, K. Griffiths, 1986, Cancer research.

Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.

R. Blamey, P. Kelly, R. Nicholson, 1997, The Journal of clinical endocrinology and metabolism.

Staging breast cancer: role of bone scanning.

R. Blamey, C. Elston, A. Morris, 1977, British medical journal.

Oestrogen receptors in primary breast cancer.

M. Williams, R. Blamey, K. Griffiths, 1985, British Journal of Cancer.

Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival.

I. Ellis, R. Blamey, J. Bell, 1990, Journal of the Royal College of Surgeons of Edinburgh.

A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer.

A. Howell, J. Forbes, R. Blamey, 1995, European journal of cancer.

Immunocytochemical localization of estrogen receptor in human breast tissue.

I. Ellis, R. Blamey, N. Bouzubar, 1988, Cancer research.

Results of first line endocrine therapy for advanced breast cancer in premenopausal women with skeletal metastases only

A. Howell, J. Forbes, R. Blamey, 1993 .

Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata.

R. Blamey, K. Griffiths, P. Davies, 1975, The Biochemical journal.

Local anaesthetic and steroid combined injection therapy in the management of non-cyclical mastalgia.

R. Blamey, R. Rampaul, H. N. Khan, 2004, Breast.

The breast pain clinic: a rational approach to classification and treatment of breast pain.

R. Blamey, C. Dowle, C. Griffith, 1987, Postgraduate medical journal.

Subcutaneous mastectomy for primary breast cancer and ductal carcinoma in situ.

I. Ellis, R. Blamey, C. Elston, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up.

I. Ellis, R. Blamey, C. Elston, 1992, European journal of cancer.

The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer.

M. Williams, R. Blamey, K. Griffiths, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group.

R. Blamey, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cosmetic assessment of breast-conserving surgery for primary breast cancer.

R. Blamey, S. Al-Ghazal, 1999, Breast.

BREAST CANCER, TAMOXIFEN, AND SURGERY

R. Blamey, I. Fentiman, J. Robertson, 1988, The Lancet.

Overexpression of Cyclin D 1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer 1

R. Blamey, J. Robertson, R. Nicholson, 1999 .

Salivary cortisol and dehydroepiandrosterone sulphate levels in postmenopausal women with primary breast cancer.

R. Blamey, K. Griffiths, F. Campbell, 1983, European journal of cancer & clinical oncology.

Initial results from a programme of breast self-examination.

R. Blamey, S. Moss, C. Elston, 1983, Clinical oncology.

Occult axillary lymph-node micrometastases in breast cancer

R. Blamey, B. Gusterson, C. Elston, 1990, The Lancet.

A controlled trial of danazol in the treatment of multiple recurrent breast cysts

M. Williams, R. Blamey, E. Roebuck, 1986, The British journal of clinical practice.

Reading the prognosis of the individual with breast cancer.

G. Ball, I. Ellis, R. Blamey, 2007, European journal of cancer.

Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer.

M. Williams, R. Blamey, K. Walker, 1985, Journal of steroid biochemistry.

Drugs for breast pain.

R. Blamey, H. Holliday, 1981, British medical journal.

The use of DNA typing to clarify the origin of metastatic carcinoma after renal transplantation

R. Blamey, M. Bishop, A. Morgan, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

In situ carcinoma of the breast.

I. Ellis, R. Blamey, C. Elston, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Immunocytochemical localization of BCL‐2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

I. Ellis, R. Blamey, J. Robertson, 1994, International journal of cancer.

BREAST RECONSTRUCTION AFTER SUBCUTANEOUS MASTECTOMY

R. Blamey, C. J. Davies, P. Doyle, 1979, The Lancet.

Long-term follow up of patients treated with a single course of danazol for recurrent breast cysts.

R. Blamey, A. Locker, E. Roebuck, 1989, British journal of clinical practice. Supplement.

A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain.

R. Blamey, P. Doyle, H. Bishop, 1986, The British journal of clinical practice.

Male breast cancer: pathological and immunohistochemical features.

I. Ellis, R. Blamey, C. Elston, 1997, Anticancer research.

Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes

A. Howell, M. Dowsett, R. Blamey, 1996, Breast Cancer Research and Treatment.

Clinical studies with the specific ‘pure’ antioestrogen ICI 182780

A. Howell, R. Blamey, J. Robertson, 1996 .

Breast Disease is now a Specialist Discipline

R. Blamey, 2006, Breast Care.

Natural killer cells in renal allograft rejection

R. Blamey, G. Cooksey, R. Robins, 1984, The British journal of surgery.

Factors influencing local recurrence after excision and radiotherapy for primary breast cancer

I. Ellis, R. Blamey, C. Elston, 1989, The British journal of surgery.

Randomised clinical trials in breast cancer

R. Blamey, 1992 .

Mammography in the pre-operative assessment and post-operative surveillance of patients treated by excision and radiotherapy for primary breast cancer.

I. Ellis, R. Blamey, C. Elston, 1990, Clinical radiology.

Patterns of flap recurrence following mastectomy

R. Blamey, C. Elston, J. Haybittle, 1985, The British journal of surgery.

Immunocytochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumours of the breast

I. Ellis, R. Blamey, C. Elston, 1988, The Journal of pathology.

Therapeutic Aspects of Screen-Detected Lesions: The Role of the Surgeon

R. Blamey, 1993 .

The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast.

I. Ellis, R. Blamey, C. Elston, 1990, The British journal of radiology.

Relationship between primary breast tumor receptor status and patient survival

J. Haybittle, R. Blamey, K. Griffiths, 1980, Cancer.

Goserelin depot in the treatment of premenopausal advanced breast cancer.

R. Blamey, M. Namer, W. Jonat, 1992, European journal of cancer.

Prognostic significance of synchronous and metachronous bilateral breast cancer

I. Ellis, R. Blamey, C. Elston, 2001, World journal of surgery.

OUTCOME INDICATORS FOR BREAST CANCER

R. Blamey, R. Priestley, J. Yarnold, 1999 .

A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients.

R. Blamey, M. Galea, 1991, Annals of the Royal College of Surgeons of England.

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival

J. Forbes, R. Blamey, J. Robertson, 1998, Oncogene.

Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.

R. W. Baldwin, I. Ellis, R. Blamey, 1985, British medical journal.

Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.

M. Williams, R. Blamey, K. Walker, 1986, The Journal of endocrinology.

Microdochectomy for single‐duct discharge from the nipple

I. Ellis, R. Blamey, C. Elston, 1988, The British journal of surgery.

Mastectomy or conservation: the patient's choice.

R. Blamey, A. Locker, T. Cotton, 1988, BMJ.

The BASO II trial of adjuvant radiotherapy. V. None and tamoxifen. V. None in small, node negative, grade I tumours

R. Blamey, U. Chetty, A. Mitchell, 2001 .

Are backup arteriovenous fistulae necessary for patients on continuous ambulatory peritoneal dialysis?

R. Blamey, M. Bishop, I. Beckingham, 1993, The Lancet.

The increasing importance of chronic rejection as a cause of renal allograft failure

R. Blamey, R. Burden, A. Morgan, 1989, Transplant international : official journal of the European Society for Organ Transplantation.

Season of initial detection in breast cancer.

R. Blamey, M. Galea, 1991, British Journal of Cancer.

Breast screening in Scandinavia

R. Blamey, 1990 .

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

R. Blamey, J. Robertson, R. Nicholson, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer.

R. Blamey, R. Nicholson, J. Robertson, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Where Bench and Field Sciences Meet: Molecular Epidemiology at NIEHS

R. Blamey, K. Griffiths, C. Elston, 1994, British journal of cancer.

Oestrogen-receptor status and sites of metastasis in breast cancer.

R. Blamey, K. Griffiths, C. Elston, 1981, British Journal of Cancer.

4. The design and clinical use of the nottingham prognostic index in breast cancer

R. Blamey, 1996 .

Plasma spermidine concentrations in patients with tumours of the breast or prostate or testis.

R. Blamey, K. Griffiths, M. Harper, 1980, Clinica chimica acta; international journal of clinical chemistry.

Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.

D N Poller, R W Blamey, I. Ellis, 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

I. Ellis, W. Foulkes, R. Blamey, 2009, Clinical Cancer Research.

A simple index to predict prognosis independent of axillary node information in breast cancer: comment.

R. Blamey, C. Elston, J. Kollias, 1998, The Australian and New Zealand journal of surgery.

The Primary Implantation of Human Tumours to the Hamster Cheek Pouch

R. Blamey, D. Evans, Dorothy E. Williams, 1971, British Journal of Cancer.

Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.

R. W. Baldwin, I. Ellis, M. Williams, 1987, British Journal of Cancer.

Helix pomatia and Ulex Europeus lectin binding in human breast carcinoma

I. Ellis, R. Blamey, C. Elston, 1987, The Journal of pathology.

Circulating immune complexes in patients with breast cancer.

R. W. Baldwin, R. Blamey, C. J. Davies, 1977, British medical journal.

Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

R. Blamey, K. Griffiths, C. Elston, 1978, British Journal of Cancer.

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

I. Ellis, R. Blamey, A. Green, 2008, European journal of cancer.

Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.

Ian O Ellis, I. Ellis, R. Blamey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.

R. Blamey, J. Robertson, R. Nicholson, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

INK 4 a Gene Expression and Methylation in Primary Breast Cancer : Overexpression of p 16 INK 4 a Messenger RNA Is a Marker of Poor Prognosis 1

R. Blamey, J. Robertson, R. Nicholson, 2000 .

Screening women aged less than 50 years with a family history of breast cancer.

I. Ellis, R. Blamey, C. Elston, 1998, European journal of cancer.

Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

I. Ellis, M. Williams, R. Blamey, 1987, British Journal of Cancer.

The prediction of local or regional recurrence after simple mastectomy for operable breast cancer

M. Williams, R. Blamey, C. Elston, 1985, The British journal of surgery.

The Nottingham Research Programme in breast cancer.

R. Blamey, 1984, The Australian and New Zealand journal of surgery.

Steroid receptors in early breast cancer: value in prognosis.

R. Blamey, K. Griffiths, C. Elston, 1981, Journal of steroid biochemistry.

RELATIONSHIP OF ŒSTROGEN-RECEPTOR STATUS TO SURVIVAL IN BREAST CANCER

K Griffiths, J. Haybittle, R. Blamey, 1979, The Lancet.

Estrogen receptor assay in primary breast cancer and early recurrence of the disease.

R. Blamey, K. Griffiths, C. Elston, 1978, Cancer research.

Breast self-examination for the early detection of breast cancer.

R. Blamey, C. Elston, A. Manhire, 1988, The Australian and New Zealand journal of surgery.

Confirmation of a prognostic index in primary breast cancer.

I. O. Ellis, I. Ellis, M. Williams, 1987, British Journal of Cancer.

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.

R. W. Baldwin, I. Ellis, R. Blamey, 1987, British Journal of Cancer.

Preliminary results of the Nottingham breast self‐examination education programme

R. Blamey, C. Elston, E. Roebuck, 1987, The British journal of surgery.

Subcutaneous mastectomy for primary operable breast cancer

R. Blamey, C. Elston, P. Doyle, 1984, The British journal of surgery.

p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.

I. Ellis, R. Blamey, C. Elston, 1993, Human pathology.

Up‐regulation of the protein tyrosine phosphatase SHP‐1 in human breast cancer and correlation with GRB2 expression

R. Blamey, J. Robertson, R. Nicholson, 2000, International journal of cancer.

Loss of Heterozygosity in Bilateral Breast Cancer

I. Ellis, R. Blamey, S. Pinder, 2000, Breast Cancer Research and Treatment.

Early-onset breast cancer--histopathological and prognostic considerations.

I. Ellis, R. Blamey, C. Elston, 1997, British Journal of Cancer.

Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

I. Ellis, R. Blamey, J. Robertson, 1994, International journal of cancer.

Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates

I. Ellis, R. Blamey, S. Pinder, 1997, Cytopathology : official journal of the British Society for Clinical Cytology.

IMMUNE COMPLEXES AND PROGNOSIS OF HUMAN BREAST CANCER

R. W. Baldwin, R. Blamey, K. Höffken, 1978, The Lancet.

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

I. Ellis, R. Blamey, S. Pinder, 1995, British Journal of Cancer.

Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma

I. Ellis, R. Blamey, C. Elston, 1991, Breast Cancer Research and Treatment.

Cytological grading of breast carcinoma—a feasible proposition?

R. Blamey, C. Elston, I. Ellis, 1990, Cytopathology : official journal of the British Society for Clinical Cytology.

Estimation of Prognosis of the Individual with Primary Breast Cancer and its Applications

R. Blamey, 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.

I. Ellis, R. Blamey, C. Elston, 1992, British Journal of Cancer.

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.

R W Blamey, G. Ball, I. Ellis, 2007, European journal of cancer.

Metallothionein expression in human breast cancer.

H. Goulding, R. Blamey, C. Elston, 1995, British Journal of Cancer.

Steroid Receptors and Primary Breast Cancer: Their Prognostic Value

R. Blamey, K. Griffiths, C. Elston, 1984 .

Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer.

R. Blamey, R. Nicholson, J. Robertson, 1996, European journal of cancer.

Clinical and histological predictors of contralateral breast cancer.

I. Ellis, R. Blamey, C. Elston, 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.

I. Ellis, R. Blamey, C. Elston, 1991, British Journal of Cancer.

c-myc oncogene product expression and prognosis in operable breast cancer.

I. Ellis, R. Blamey, C. Elston, 1989, British Journal of Cancer.

Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.

I. Ellis, R. Blamey, C. Elston, 1989, British Journal of Cancer.

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

S. Duffy, R. Blamey, S. Pinder, 2013, European journal of cancer.

ONCOPOOL - a European database for 16,944 cases of breast cancer.

M. J. van de Vijver, G. Ball, I. Ellis, 2010, European journal of cancer.

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.

I. Ellis, R. Blamey, C. Elston, 2009, European journal of cancer.

The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology

I. Ellis, R. Blamey, E. Rakha, 2009, Breast Cancer Research and Treatment.

I. Ellis, R. Blamey, S. Pinder, 2004, Breast Cancer Research and Treatment.

E-cadherin as a prognostic indicator in primary breast cancer

R. Blamey, S. Pinder, J. Robertson, 2001, British Journal of Cancer.

c-erbB-4 protein expression in human breast cancer

I. Ellis, R. Blamey, S. Pinder, 2000, British Journal of Cancer.

Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer.

I. Ellis, R. Blamey, C. Elston, 1995, European journal of cancer.

Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?

I. Ellis, R. Blamey, C. Elston, 1995, Human pathology.

A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples.

R W Blamey, R. Blamey, S. Pinder, 1995, Human pathology.

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.

I. Ellis, R. Blamey, C. Elston, 1991, British Journal of Cancer.

Cathepsin D in primary breast carcinoma: Adverse prognosis is associated with expression of cathepsin D in stromal cells

I. Ellis, R. Blamey, C. Elston, 2004, Breast Cancer Research and Treatment.

A monoclonal antibody, NCRC‐11, raised to human breast carcinoma. 1. Production and immunohistological characterization

R. W. Baldwin, I. Ellis, R. Blamey, 1984, Histopathology.

Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluids.

R. W. Baldwin, M. Williams, R. Blamey, 1987, European Journal of Cancer and Clinical Oncology.

DNA fingerprinting of benign and malignant breast lesions.

I. Ellis, R. Blamey, C. Elston, 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.

M. Williams, R. Blamey, K. Walker, 1986, British Journal of Cancer.

Selection of Primary Breast Cancer Patients for Adjuvant Endocrine Therapy – is Oestrogen Receptor Alone Adequate?

R. Blamey, R. Nicholson, K. Cheung, 2004, Breast Cancer Research and Treatment.

Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue.

R. Blamey, K. Walker, R. Nicholson, 1992, European journal of cancer.

Tubular carcinoma of the breast: further evidence to support its excellent prognosis.

I. Ellis, R. Blamey, E. Rakha, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The psychological impact of immediate rather than delayed breast reconstruction.

R. Blamey, S. Al-Ghazal, L. Fallowfield, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?

I. Ellis, R. Blamey, S. Pinder, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

R. Blamey, R. Blamey, R. Sylvester, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of epidermal growth factor receptor in breast carcinoma.

R W Blamey, I. Ellis, R. Blamey, 1990, Journal of clinical pathology.

Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer.

R. Blamey, K. Griffiths, C. Elston, 1983, British Journal of Cancer.

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.

J. Cuzick, W. Sauerbrei, R. Blamey, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Guidelines on endocrine therapy of breast cancer EUSOMA.

R. Blamey, 2002, European journal of cancer.

Differential expression of oestrogen regulated genes in breast cancer.

R. Blamey, J. Robertson, R. Sutherland, 1995, Acta oncologica.

An observation of DNA ploidy, histological grade, and immunoreactivity for tumour‐related antigens in primary and metastatic breast carcinoma

I. Ellis, R. Blamey, C. Elston, 1989, The Journal of pathology.

Zoladex® plus tamoxifen versus zoladex® alone in pre- and peri-menopausal metastatic breast cancer

R. Blamey, K. Walker, R. Blamey, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Estradiol induction of retinoic acid receptors in human breast cancer cells.

R. Blamey, R. Nicholson, C. Clarke, 1993, Cancer research.

Transforming growth factor-alpha and endocrine sensitivity in breast cancer.

I. Ellis, R. Blamey, J. Robertson, 1994, Cancer research.

Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement.

I. Ellis, R. Blamey, C. Elston, 1994, European journal of cancer.

Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?

L Fallowfield, R W Blamey, R. Blamey, 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast transillumination using the sinus diaphanograph.

R. Blamey, H. Holliday, 1981, British medical journal.

A comparison of the use of the ‘Tru‐Cut’ needle and fine needle aspiration cytology in the pre‐operative diagnosis of carcinoma of the breast

R. Blamey, C. Elston, C. J. Davies, 1978, Histopathology.

Use of older patients as cadaveric kidney donors

R. Blamey, M. Bishop, P. Rowe, 1988, The British journal of surgery.

Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer.

R. Blamey, K. Walker, K. Griffiths, 1989, European journal of cancer & clinical oncology.

Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer.

R. Blamey, K. Walker, K. Griffiths, 1984, Journal of steroid biochemistry.

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.

A. Howell, R. Blamey, D. Smith, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.

M. Knapp, R. Blamey, C. Wilson, 1978, Clinical nephrology.

Experiments in tumour immunology

R. Blamey, 1968, The British journal of surgery.

Postoperative radiotherapy following mastectomy for high-risk breast cancer. A randomised trial.

R. Blamey, D. Morgan, J. Berridge, 2002, European journal of cancer.

Ductal Carcinoma In-Situ Of The Breast: A new simplified histological classification. Association between cellular proliferation and c-erbB-2 protein expression

I. Ellis, R. Blamey, C. Elston, 1992 .

An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.

I. Ellis, R. Blamey, C. Elston, 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Generic substitution

R. Blamey, 1983 .

Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction.

L Fallowfield, R W Blamey, R. Blamey, 2000, European journal of cancer.

Reply to Editorial Comment

R. Blamey, 2002 .

The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research.

R. Blamey, I. Andersson, 2002, European journal of cancer.

Prediction of survival in the individual with breast cancer.

R. Blamey, 1999, The Australian and New Zealand journal of surgery.

Node negative breast cancer.

I. Ellis, R. Blamey, C. Elston, 1990, BMJ.

Relationship of oestrogen-receptor status to survival in breast cancer.

K Griffiths, R W Blamey, R. Blamey, 1979, Lancet.

Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis.

I. Ellis, R. Blamey, C. Elston, 1995, The British journal of radiology.

Reading the prognosis of the individual with breast cancer.

G. Ball, I. Ellis, R. Blamey, 2007, European journal of cancer.

O-46 The prognosis of small breast cancers and selection for omission of adjuvant chemotherapy

R. Blamey, M. Kerin, K. Holli, 2007 .

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

I. Ellis, R. Blamey, C. Elston, 1993, British Journal of Cancer.

Mammographic and pathological features of breast cancer detected at first incident round screening

I. Ellis, L. Yeoman, R. Blamey, 1997 .

Screening interval breast cancers: mammographic features and prognosis factors.

L J Yeoman, R W Blamey, I. Ellis, 1996, Radiology.

98. Mammographic features of interval cancers and prognosis compared with screen detected and symptomatic breast cancers

L. Yeoman, R. Blamey, S. Pinder, 1995 .

Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.

D Nicholson, R W Blamey, R. Blamey, 1990, Cancer research.

Value of Contralateral Surveillance Mammography for Primary Breast Cancer Follow-up

I. Ellis, R. Blamey, C. Elston, 2000, World Journal of Surgery.

Endocrine treatment of physiological gynaecomastia

R. Blamey, H. N. Khan, 2003, BMJ : British Medical Journal.

MANAGEMENT OF INTRA-DUCT CARCINOMA

R. Blamey, D. Morgan, C. Hinton, 1984, The Lancet.

Results from a seven-year programme of breast self-examination in 89,010 women.

R. Blamey, C. Elston, R. Blamey, 1989, British Journal of Cancer.

The Nottingham breast self-examination project.

R. Blamey, A. Mitchell, A. Locker, 1989, Acta oncologica.

Results from a seven-year programme of breast self-examination in 89,010 women

R. Blamey, C. Elston, A. Mitchell, 1990 .

Therapeutic potential of the lh-rh agonist zoladex (ICI 118630) in the treatment of advanced breast cancer in pre and postmenopausal women

R. Blamey, K. Walker, R. Nicholson, 1984 .

Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy

I. Ellis, R. Blamey, J. Robertson, 2004, Breast Cancer Research and Treatment.

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers

I. Ellis, R. Blamey, J. Reis-Filho, 2010, The Journal of pathology.

EUSOMA accreditation of breast units.

R. Blamey, L. Cataliotti, 2006, European journal of cancer.

The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer.

R. Blamey, R. Nicholson, R. McClelland, 1993, European journal of cancer.

A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients

Paulo J. G. Lisboa, Jonathan M. Garibaldi, Elia Biganzoli, 2010, Comput. Biol. Medicine.

Differential expression of estrogen-regulated genes in breast-cancer

R. Blamey, R. Nicholson, J. Robertson, 1995 .

Are you a typer, grader or a molecular convert? Prognostic assessment of operable breast carcinoma

I. Ellis, R. Blamey, S. Pinder, 1992 .

Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer.

M. Williams, R. Blamey, K. Griffiths, 1985, AJR. American journal of roentgenology.

Bilateral breast carcinomas: do they have similar mammographic features?

I. Ellis, R. Blamey, S. Pinder, 1999, Clinical radiology.

Spleen Weight in Rats During Tumour Growth and in Homograft Rejection

R. Blamey, D. Evans, 1971, British Journal of Cancer.

Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.

N. Day, S. Duffy, J. Cuzick, 2001, Journal of epidemiology and biostatistics.

Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer.

R. Blamey, W. Jonat, M. Kaufmann, 1993, European journal of cancer.

Timing breast cancer surgery

J. Forbes, R. Gelber, R. Blamey, 1991, The Lancet.

Survival patterns in hormone treated advanced breast cancer

M. Williams, R. Blamey, K. Griffiths, 1986, The British journal of surgery.

Pure antioestrogens in breast cancer - experimental and clinical observations

A. Howell, M. Dowsett, R. Mansel, 1994 .

Safe criteria for breast conservation without radical excision

I. Ellis, R. Blamey, C. Elston, 1993 .

Biological and clinical aspects of oestrogen receptor measurements in rapidly progressing breast cancer

M. Williams, R. Blamey, K. Griffiths, 1984 .

Preoperative diagnosis in carcinoma of the breast

R. Blamey, C. Elston, C. J. Davies, 1977, The British journal of surgery.

Guidelines on the standards for the training of specialised health professionals dealing with breast cancer.

C. de Wolf, E. van Limbergen, I. Ellis, 2007, European journal of cancer.

86. Pharmacokinetics, systemic and antitumour effects of the specific antioestrogen ICI 182780 in women with advanced breast cancer

A. Howell, R. Blamey, J. Robertson, 1995 .

ABC of breast diseases: screening for breast cancer.

R W Blamey, R. Blamey, A. Wilson, 2000, BMJ.

TRIALS OF ADJUVANT CHEMOTHERAPY IN BREAST CANCER

R. Blamey, C. Elston, 1979, The Lancet.

Phenotypic drift does not happen but lots of interesting things do

R. Blamey, 1993 .

A comparison of the characteristics and prognosis of screen detected and symptomatic breast cancers

I. Ellis, R. Blamey, C. Elston, 1993 .

Availability of organs for transplantation: a three year study.

R. Blamey, B. Smithers, G. Cooksey, 1986, British medical journal.

Measurement of the immune response to an allograft: Amino acid incorporation by peripheral white blood cells in man

R. Blamey, R. Bennett, J. Harrison, 1975, The British journal of surgery.

A comparison outcome of male breast cancer with female breast cancer.

I. Ellis, R. Blamey, R. Blamey, 1997, American journal of surgery.

Paget's disease of the nipple

I. Ellis, R. Blamey, C. Elston, 1991, The British journal of surgery.

Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival.

R. Blamey, J. Robertson, R. Blamey, 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Comments on NCI Alert on node-negative breast cancer

R. Blamey, C. Elston, A. Locker, 1989, Breast Cancer Research and Treatment.

Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team.

D N Poller, I. Ellis, L. Yeoman, 1993, Clinical radiology.

A comparison of fine needle aspiration cytology and tru-cut tissue biopsy in the diagnosis of acute renal allograft rejection.

R. Blamey, R. Burden, P. Wenham, 1986, Nephron.

HISTOLOGICAL GRADE AND RESPONSE TO ENDOCRINE THERAPY IN BREAST CANCER

R. Blamey, K. Griffiths, C. Elston, 1981, The Lancet.

MEDICAL RESEARCH COUNCIL TRIAL OF ANTILYMPHOCYTE GLOBULIN IN RENAL TRANSPLANTATION: A MULTICENTER RANDOMIZED DOUBLE‐BLIND PLACEBO CONTROLLED CLINICAL INVESTIGATION

R. Peto, R. Blamey, S. Richards, 1983, Transplantation.

Prognostic significance of synchronous and metachronous bilateral breast cancer

I. Ellis, R. Blamey, C. Elston, 2011, World Journal of Surgery.